Biomedical Engineering Reference
In-Depth Information
28. Simberg D, Park JH, Karmali PP, Zhang WM, Merkulov S, McCrae K, Bhatia SN, Sailor M,
Ruoslahti E (2009) Differential proteomics analysis of the surface heterogeneity of dextran
iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials
30:3926-3933
29. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth
T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH
(2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma
corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155-7167
30. Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlback B, Dawson KA, Linse S,
Cedervall T (2009) Complete high-density lipoproteins in nanoparticle corona. FEBS J
276:3372-3381
31. Stayton PS, Drobny GP, Shaw WJ, Long JR, Gilbert M (2003) Molecular recognition at the
protein-hydroxyapatite interface. Crit Rev Oral Biol Med 14:370-376
32. Prakasham RS, Devi GS, Rao CS, Sivakumar VS, Sathish T, Sarma PN (2010) Nickel-
impregnated silica nanoparticle synthesis and their evaluation for biocatalyst immobilization.
Appl Biochem Biotechnol 160:1888-1895
33. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA (2010) What the cell “sees” in
bionanoscience. J Am Chem Soc 132:5761-5768
34. Montes-Burgos I, Walczyk D, Hole P, Smith J, Lynch I, Dawson K (2009) Characterisation of
nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res 12:47-53